NDC 70518-2780-1 - Naloxone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2780
- Requested NDC
- 70518-2780-1
- Package NDCs from labels
- 70518-2780-1, 70518-2780-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naloxone Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2780-0 | 2022-02-02 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
| 70518-2780-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Baxter Healthcare Corporation | 3d8813be-6d22-46f1-ac25-0d8a817a521c | 2020-11-25 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Mylan Institutional LLC | f0932877-1f3b-4d5e-82d2-dd6c53db4730 | 2020-08-17 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALXONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 8cc25cf1-008c-4808-baec-49f35a887fae | 2020-03-20 | Warnings, Adverse reactions | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.